- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01817296
Klinefelter Fertility Preservation
May 14, 2014 updated by: Boston Children's Hospital
Klinefelter Syndrome: Are we Missing the Optimal Time for Fertility Preservation?
Klinefelter syndrome occurs in 1 in 600 males and is a common cause of infertility in men.
It appears scar tissue forms in these boys' testicles, leading to progressive destruction over their lifetimes.
Advanced reproductive technology can be used to surgically retrieve sperm from these individuals, but these methods have a 50% failure rate in adult Klinefelter patients.
Younger men have higher success rates, suggesting that adolescence and young adulthood may be the best time to extract sperm, but these techniques have not been studied in Klinefelter patients younger than 26 years of age.
Additionally, there is currently no way to predict which Klinefelter patients will have success with these methods and which of them will not.
This trial will explore sperm extraction in Klinefelter syndrome in an age range (12-25 years) that has never been studied, with the ultimate hope of improving the potential for fertility in these patients.
The specific goals of this study are to determine the ideal age for sperm retrieval in Klinefelter patients and to establish factors that can be used to predict which of these patients will have a higher likelihood of success with advanced reproductive technology.
The hypothesis is that younger Klinefelter patients will have higher sperm retrieval rates.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
15
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 23 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- diagnosed 47,XXY (Klinefelter syndrome)
- 12-25 years of age
Exclusion Criteria:
- testosterone therapy within past 6 months
- history of surgery, injury, or infection in the testicle
- solitary testicle
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Single arm
|
Micro-dissection testicular sperm extraction for sperm retrieval
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sperm retrieval rates based on age
Time Frame: Assessed at the end of the 6 month study period
|
Results of testicular biopsies will be reviewed for each patient during the 6 month study period
|
Assessed at the end of the 6 month study period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Correlation between sperm retrieval rates and physical and biochemical markers
Time Frame: Assessed at the end of the 6 month study period
|
Results of testicular biopsies will be correlated to physical and biochemical markers for each patient after all of the data have been collected, during the 6 month study period.
|
Assessed at the end of the 6 month study period
|
Correlation between sperm retrieval rates and neurocognitive survey data
Time Frame: Assessed at the end of the 6 month study period
|
Results of testicular biopsies will be correlated to neurocognitive survey data for each patient after all of the data have been collected, during the 6 month study period.
|
Assessed at the end of the 6 month study period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2013
Primary Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
March 13, 2013
First Submitted That Met QC Criteria
March 20, 2013
First Posted (Estimate)
March 25, 2013
Study Record Updates
Last Update Posted (Estimate)
May 15, 2014
Last Update Submitted That Met QC Criteria
May 14, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Endocrine System Diseases
- Disease
- Gonadal Disorders
- Disorders of Sex Development
- Urogenital Abnormalities
- Congenital Abnormalities
- Genetic Diseases, Inborn
- Chromosome Disorders
- Sex Chromosome Disorders
- Sex Chromosome Disorders of Sex Development
- Hypogonadism
- Syndrome
- Klinefelter Syndrome
Other Study ID Numbers
- 4093
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Klinefelter Syndrome
-
University Hospital MuensterCompletedKlinefelter Syndrome, Hypogonadism
-
Lenetix Medical Screening LaboratoryUnknownDown Syndrome (Trisomy 21) | Edward's Syndrome (Trisomy 18) | Patau Syndrome (Trisomy 13) | Klinefelter Syndrome (47, XXY) | and Other Chromosome | Abnormalities.United States
-
University of Colorado, DenverNational Institute of Neurological Disorders and Stroke (NINDS); Children's... and other collaboratorsCompletedKlinefelter Syndrome | XXY SyndromeUnited States
-
Hospices Civils de LyonCompletedKlinefelter SyndromeFrance
-
University of PittsburghTerminated
-
Odense University HospitalAarhus University Hospital; University of CopenhagenCompleted
-
University of Colorado, DenverRecruitingKlinefelter Syndrome | Trisomy X | XYY Syndrome | XXXY and XXXXY Syndrome | Xxyy Syndrome | Xyyy Syndrome | Xxxx Syndrome | Xxxxx Syndrome | Xxxyy Syndrome | Xxyyy Syndrome | Xyyyy Syndrome | Male With Sex Chromosome MosaicismUnited States
-
Thomas Jefferson UniversityNational Institute of Neurological Disorders and Stroke (NINDS)Completed
-
University of Colorado, DenverCompletedKlinefelter SyndromeUnited States
Clinical Trials on Testicular Biopsy
-
University of EdinburghUniversity of OxfordRecruitingChildhood Cancer | Fertility DisordersUnited Kingdom
-
Fundación IVIRecruitingDNA Damage | IVF | Oligospermia | ICSI | EmbryoSpain
-
University of PittsburghWashington University School of Medicine; University of Miami; University of... and other collaboratorsRecruitingCancer | Autoimmune DisordersUnited States
-
Odense University HospitalCompleted
-
Cliniques universitaires Saint-Luc- Université...RecruitingInfertility, Male | Klinefelter SyndromeBelgium
-
University of Colorado, DenverWithdrawn
-
Centre Hospitalier Universitaire de NiceTerminatedTesticular CancerFrance
-
Hospices Civils de LyonCompletedKlinefelter SyndromeFrance
-
Hadassah Medical OrganizationUnknownOncology [See Also, Affected System]Israel
-
Gumy-Pause FabienneRecruitingChildhood Cancer | Fertility DisordersSwitzerland